Levetiracetam versus valproate for new-onset or previously treated but inadequately controlled epilepsy in children: a systematic review and meta-analysis of randomized controlled trials
European Journal of Clinical Pharmacology · 2026-11 · 82 (11)
DOI: 10.1007/s00228-026-04201-9 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 20.10.2026. Verfasst von Abdullah M Alharran und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain. Dr_alharran@outlook.com. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Levetiracetam, Valproic Acid. Die Arbeit nennt 37 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Purpose
To compare the efficacy and safety of levetiracetam versus valproate in children with new-onset or previously treated but inadequately controlled epilepsy.
Methods
We systematically searched PubMed, Scopus, Web of Science, and Cochrane Library from inception to April 2026 for randomized controlled trials (RCTs) comparing levetiracetam versus valproate in children (aged 0–18 years) with new-onset or previously treated but inadequately controlled epilepsy. Outcomes included seizure freedom, exploratory analyses of survival time without seizure and time to first seizure recurrence, change in aspartate aminotransferase (AST) levels, and adverse events.
Results
Eight RCTs involving 1,000 participants were included. Seizure freedom did not differ significantly between treatments (5 studies, 655 participants; RR = 0.95, 95% CI: 0.83–1.09; P = 0.45; I² = 59.5%; low-certainty evidence). Exploratory time-related outcomes favored valproate but were limited by low-certainty evidence and inadequate handling of censoring. Levetiracetam was associated with lower AST levels, although this did not establish superior hepatic safety, and with fewer overall adverse events and less weight gain.
Conclusions
No significant difference in seizure freedom was detected between levetiracetam and valproate, although the low-certainty finding was sensitive to one trial. Time-related outcomes favored valproate but were exploratory and limited by inadequate handling of censoring. Levetiracetam was associated with fewer overall adverse events and less weight gain, while behavioral and hepatic safety remained uncertain. Treatment should be individualized based on patient and medication-related factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain. Dr_alharran@outlook.com.
- Kuwait Institute for Medical Specialization, Kuwait City, Al Asimah, Kuwait.
- Royal College of Surgeons in Ireland, Dublin, Ireland.
- College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.
Zitieren
APA
Alharran, A. M., Alsaleeli, K. M., Alkhamis, A. S., Taqi, B. A., Altaher, R., Alenezi, R. A., Mohammad, H. F., Dashti, R. H., Mugheer, A. M., Alshemeri, R. G., Alarki, A. A., & Abdalkareem, S. O. (2026). Levetiracetam versus valproate for new-onset or previously treated but inadequately controlled epilepsy in children: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Pharmacology, 82(11). https://doi.org/10.1007/s00228-026-04201-9
Vancouver
Alharran AM, Alsaleeli KM, Alkhamis AS, Taqi BA, Altaher R, Alenezi RA, et al. Levetiracetam versus valproate for new-onset or previously treated but inadequately controlled epilepsy in children: a systematic review and meta-analysis of randomized controlled trials. European Journal of Clinical Pharmacology. 2026;82(11). doi:10.1007/s00228-026-04201-9
BibTeX
@article{Alharran2026,
author = {Alharran, Abdullah M and Alsaleeli, Khaled M and Alkhamis, Ahmed S and Taqi, Batoul A and Altaher, Rawan and Alenezi, Renad A and Mohammad, Haya F and Dashti, Ruqayah H and Mugheer, Asmaa M and Alshemeri, Reem Gh and Alarki, Alzain A and Abdalkareem, Sarah Onh},
title = {Levetiracetam versus valproate for new-onset or previously treated but inadequately controlled epilepsy in children: a systematic review and meta-analysis of randomized controlled trials},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {11},
doi = {10.1007/s00228-026-04201-9}
}
EUVIMED